Mass drug administrations with dihydroartemisinin-piperaquine and single low dose primaquine to eliminate Plasmodium falciparum have only a transient impact on Plasmodium vivax: Findings from randomised controlled trials

Phommasone K., van Leth F., Peto TJ., Landier J., Nguyen T-N., Tripura R., Pongvongsa T., Lwin KM., Kajeechiwa L., Thwin MM., Parker DM., Wiladphaingern J., Nosten S., Proux S., Nguon C., Davoeung C., Rekol H., Adhikari B., Promnarate C., Chotivanich K., Hanboonkunupakarn B., Jittmala P., Cheah PY., Dhorda M., Imwong M., Mukaka M., Peerawaranun P., Pukrittayakamee S., Newton PN., Thwaites GE., Day NPJ., Mayxay M., Hien TT., Nosten FH., Cobelens F., Dondorp AM., White NJ., von Seidlein L.

DOI

10.1371/journal.pone.0228190

Type

Journal

PLOS ONE

Publisher

Public Library of Science (PLoS)

Publication Date

05/02/2020

Volume

15

Pages

e0228190 - e0228190

Permalink Original publication